Consolidated Statement of Cash Flows
(Unit: million yen)
| 2021 december |
2022 december |
2023 december |
2024 december |
2025 december |
|
|---|---|---|---|---|---|
| Cash flow from operating activities | |||||
| Net income before income taxes | 1,523 | 8,372 | 8,378 | 10,071 | 14,099 |
| depreciation | 3,181 | 2,828 | 2,641 | 2,744 | 4,036 |
| Amortization of goodwill | 406 | 411 | 252 | 363 | 131 |
| Impairment loss | 2,038 | 1,319 | 0 | - | 259 |
| Increase/decrease in allowance for doubtful accounts (△ indicates decrease) | 8 | △508 | 18 | △45 | △9 |
| Increase/decrease in bonus reserve (△ indicates decrease) | 124 | 983 | 907 | △856 | 1,406 |
| Increase/decrease in directors' bonus reserves (△ indicates decrease) | 41 | 29 | 163 | △86 | 109 |
| Increase/decrease in provision for loss on orders received (△ indicates decrease) | △4 | 1 | △1 | 3 | △2 |
| Increase (decrease) in retirement benefit liabilities | 119 | 59 | △28 | △22 | △225 |
| Increase/decrease in assets related to retirement benefits (△ indicates increase) | △11 | △14 | △30 | △34 | 37 |
| Increase/decrease in reserve for directors' retirement benefits (△ indicates decrease) | 10 | 5 | △9 | △8 | △71 |
| Increase/decrease in provision for product warranties (△ indicates decrease) | △13 | △42 | △3 | △1 | 2 |
| Increase/decrease in provision for losses on business of affiliated companies (△ indicates decrease) | - | 323 | △224 | △35 | 1 |
| Increase/decrease in provision for losses related to competition law (△ indicates decrease) | - | - | - | 728 | △734 |
| Increase/decrease in provision for losses related to voluntary product recalls (△ indicates decrease) | - | - | - | 126 | △43 |
| Interest and dividend income | △117 | △104 | △128 | △138 | △155 |
| Interest paid | 162 | 151 | 151 | 306 | 519 |
| Equity in earnings of affiliates (△ indicates profit) | - | 6 | 16 | - | - |
| Gain/loss on sale of investment securities (△ indicates gain) | △296 | △95 | △169 | △25 | △221 |
| Gain or loss on sale of fixed assets (△ indicates gain) | △1,169 | △6,882 | △2 | △538 | △570 |
| Loss on disposal of fixed assets | 122 | 1,782 | 328 | 156 | 164 |
| Valuation gains/losses on investment securities (△ indicates gains) | 64 | - | - | - | - |
| Put option liabilities written to non-controlling interests Valuation profit/loss (△ is profit) |
- | - | - | △578 | - |
| Increase/decrease in accounts receivable (△ indicates increase) | △86 | △1,735 | △3,124 | 1,219 | △6,636 |
| Increase/decrease in inventory assets (△ indicates increase) | △1,260 | △138 | 197 | △941 | △2,203 |
| Increase/decrease in accounts payable (△ indicates decrease) | 510 | 842 | 390 | △10,312 | 655 |
| Others | △563 | 35 | 477 | △1,662 | 2,727 |
| subtotal | 4,790 | 7,630 | 10,202 | 429 | 13,275 |
| Interest and dividends received | 114 | 102 | 118 | 162 | 155 |
| Interest payments | △164 | △147 | △137 | △320 | △477 |
| Settlement payment amount | - | - | - | △400 | - |
| Competition Law-Related Payments | - | - | - | - | △734 |
| Corporate tax payment or refund amount (△ indicates payment) | △1,966 | △1,782 | △3,862 | △872 | △3,277 |
| Cash flow from operating activities | 2,774 | 5,804 | 6,321 | △1,000 | 8,942 |
| Cash flow from investing activities | |||||
| Expenditures for time deposits | △1,327 | △1,533 | △4,150 | △1,392 | △1,270 |
| Income from withdrawal of fixed term deposits | 1,320 | 1,631 | 4,491 | 1,534 | 1,450 |
| Expenditures for the acquisition of tangible fixed assets | △2,110 | △4,145 | △3,316 | △3,146 | △3,749 |
| Proceeds from sales of property, plant and equipment | 2,160 | 9,633 | 52 | 586 | 1,220 |
| Expenditures for the acquisition of intangible fixed assets | - | - | △1,235 | △2,890 | △2,268 |
| Expenditures for acquisition of investment securities | △862 | △65 | △540 | △252 | △252 |
| Proceeds from sales of investment securities | 800 | 301 | 351 | 84 | 466 |
| Net increase/decrease in short-term loans (△ indicates increase) | - | - | - | 29 | - |
| Long-term loan expenditures | - | - | - | △4 | △283 |
| Revenue from collection of long-term loans | 2 | 0 | 0 | 0 | 1 |
| Changes in the scope of consolidation Expenditures for acquisition of subsidiary shares |
- | △36 | - | △928 | - |
| Net increase/decrease in insurance reserves (△ indicates increase) | △246 | △33 | 395 | △608 | 832 |
| Others | △908 | △829 | △59 | △119 | 5 |
| Cash flow from investing activities | △1,170 | 4,923 | △4,012 | △7,107 | △3,847 |
| Cash flow from financing activities | |||||
| Net increase/decrease in short-term borrowings (△ indicates decrease) | △385 | △100 | △981 | 12,797 | △8,453 |
| Proceeds from long-term borrowings | 1,815 | 2,615 | 1,231 | 11,161 | 10,480 |
| Repayment of long-term loans | △2,530 | △2,288 | △1,881 | △3,459 | △9,835 |
| Income from issuing corporate bonds | - | - | - | - | 4,969 |
| Expenditures for redemption of corporate bonds | △40 | △40 | △60 | △7 | △14 |
| Net increase/decrease in treasury stock (△ indicates increase) | △0 | △0 | △0 | △15,901 | △3 |
| Proceeds from issuance of shares upon exercise of stock acquisition rights | - | - | - | 4,069 | - |
| Dividend payment amount | △586 | △678 | △1,675 | △1,901 | △2,704 |
| Dividends paid to non-controlling shareholders | △0 | △0 | △0 | △0 | △0 |
| No change in the scope of consolidation Expenditures for acquisition of subsidiary shares |
- | - | △1 | △360 | - |
| Others | △930 | △934 | △778 | △494 | △381 |
| Cash flow from financing activities | △2,658 | △1,426 | △4,148 | 5,905 | △5,941 |
| Effect of exchange rate changes on cash and cash equivalents | 155 | 239 | 83 | 32 | 58 |
| Increase/decrease in cash and cash equivalents (△ indicates decrease) | △900 | 9,541 | △1,755 | △2,170 | △787 |
| Cash and cash equivalents at beginning of period | 16,697 | 15,797 | 25,420 | 23,664 | 21,494 |
| Due to change in the fiscal year end of consolidated subsidiaries Increase/decrease in cash and cash equivalents (△ indicates decrease) |
- | 81 | - | - | - |
| Due to new consolidation Increase in cash and cash equivalents |
- | - | - | - | 113 |
| Ending balance of cash and cash equivalents | 15,797 | 25,420 | 23,664 | 21,494 | 20,820 |
- Investor Relations
- IR News
- Top message
- To all individual investors
- IR Policies
- IR resource room
- Performance/finance
- Performance highlights (consolidated)
- Financial situation (consolidated)
- Cash flow status (consolidated)
- Consolidated income statement
- Consolidated Balance Sheets
- Consolidated Statement of Cash Flows
- Financial and Non-Financial Data
- Stock information
- IR event
- Dialogue with shareholders (IR activities)
- FAQ